{"id":248,"date":"2014-03-01T10:20:00","date_gmt":"2014-03-01T14:20:00","guid":{"rendered":"http:\/\/jaydub.cms-devl.bu.edu\/aodhealth\/2014\/01\/01\/barriers-and-facilitators-for-hcv-treatment-engagement-within-integrated-care-delivery-models\/"},"modified":"2017-01-31T11:45:09","modified_gmt":"2017-01-31T16:45:09","slug":"barriers-and-facilitators-for-hcv-treatment-engagement-within-integrated-care-delivery-models","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/aodhealth\/2014\/03\/01\/barriers-and-facilitators-for-hcv-treatment-engagement-within-integrated-care-delivery-models\/","title":{"rendered":"Barriers  and Facilitators for HCV Treatment Engagement within Integrated Care Delivery Models"},"content":{"rendered":"<div class=\"research-summary-body\">\n                    <!-- InstanceBeginEditable name=\"contents\" --><\/p>\n<p>Uptake of hepatitis  C (HCV) treatment among patients with opioid use disorders tends to be low. This  qualitative investigation explored the barriers and facilitators affecting the  delivery and uptake of HCV care and treatment within opioid treatment programs.  Patients, healthcare professionals, and peer workers from the centers were  recruited for in-depth, semi-structured interviews. Patient participants were  separated into three groups: those without engagement in HCV care; those who  were assessed for HCV care but did not follow through with further care or  treatment; and those who were actively engaged in HCV care and treatment. <\/p>\n<ul type=\"disc\">\n<li>Overall,       76 interviews were completed; 56 were with patients and 19 were with staff. <\/li>\n<li>Differences       emerged between the patient groups. Among those who never engaged in HCV       care, barriers included the participants\u2019 perception that they were       physically well and asymptomatic, other life priorities, and concern about       side effects of treatment. Patients who engaged in care were motivated by       close contacts becoming sick, wanting to live longer, and hearing positive       stories of treatment. <\/li>\n<li>Presence       of an engaged clinician and treatment accessibility facilitated patients\u2019 engagement       in this integrated care model. <\/li>\n<\/ul>\n<p><!-- InstanceEndEditable --><\/p>\n<div class=\"research-summary-footnotes-1\">\n\t\t\t\t\t\t<!-- InstanceBeginEditable name=\"footnotes-1\" --><!-- InstanceEndEditable -->\n\t\t\t\t\t<\/div>\n<h2 class=\"research-summary-comments\">Comments:<\/h2>\n<p>\t\t\t\t\t<!-- InstanceBeginEditable name=\"comments\" -->This  investigation supports previous reports that integrated care delivery models of  HCV treatment within opioid agonist treatment settings improve engagement in  HCV care. Increasing education and outreach and the development of more  tolerable treatment regimens show promise for improving HCV treatment  engagement among patients with opioid use disorder. <!-- InstanceEndEditable --><br \/>\n                    <cite><br \/>\n\t\t\t\t\t\t<!-- InstanceBeginEditable name=\"name\" -->Jeanette M. Tetrault,  MD<!-- InstanceEndEditable --><br \/>\n\t\t\t\t\t<\/cite><\/p>\n<div class=\"research-summary-footnotes\">\n\t\t\t\t\t<!-- InstanceBeginEditable name=\"footnotes\" --><!-- InstanceEndEditable -->\n\t\t\t\t\t<\/div>\n<h2>Reference:<\/h2>\n<p>\t\t\t\t\t<!-- InstanceBeginEditable name=\"reference\" --><\/p>\n<p>Treloar C, Rance J,  Dore GJ, Grebely J. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24299222\">Barriers and facilitators for assessment and treatment of  hepatitis C virus infection in the opioid substitution treatment setting:  insights from the ETHOS study<\/a>. <em>J Viral  Hepat. <\/em>2013 [Epub ahead of print]. doi: 10.1111\/jvh.12183.<\/p>\n<p>\t<!-- InstanceEndEditable -->\n\t\t\t\t<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Uptake of hepatitis C (HCV) treatment among patients with opioid use disorders tends to be low. This qualitative investigation explored the barriers and facilitators affecting the delivery and uptake of HCV care and treatment within opioid treatment programs. Patients, healthcare professionals, and peer workers from the centers were recruited for in-depth, semi-structured interviews. Patient participants [&hellip;]<\/p>\n","protected":false},"author":11272,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[33],"tags":[73],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/posts\/248"}],"collection":[{"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/users\/11272"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/comments?post=248"}],"version-history":[{"count":1,"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/posts\/248\/revisions"}],"predecessor-version":[{"id":2168,"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/posts\/248\/revisions\/2168"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/media?parent=248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/categories?post=248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/aodhealth\/wp-json\/wp\/v2\/tags?post=248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}